GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: NP-10679
NP10679 is an approved drug
Compound class:
Synthetic organic
Comment: NP10679 is an orally bioavailable,brain penetrant GluN2B-selective NMDA receptor inhibitor [1-2]. It offers potential to reduce acute brain injury (subsequent to ischemic stroke or aneurysmal subarachnoid hemorrhage) and for treatment of neuropsychiatric indications [3].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
NP10679 is selective for GluN2B, over GluN2A, GluN2C, or GluN2D receptors [1]. Binding to 5-HT2A, α1A-adrenoceptors, histamine H1 receptors and the serotonin transporter (SERT) has been detected by radioligand displacement assay (Ki values are 638 nM, 603 nM, 40 nM and 135 nM respectively) [1]. |
Selectivity at ion channels | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|